ASKA Pharmaceutical Holdings CO., Ltd.【JP:4886】Balance sheet
Market cap
¥71.1B
P/E ratio
14x
| 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 12,103 | 14,505 | 13,738 | 10,603 |
| Marketable securities, current | - | 5,000 | 3,400 | 3,500 | 555 |
| Total cash & short-term investments | - | 17,103 | 17,905 | 17,238 | 11,158 |
| Inventories | - | 10,016 | 10,815 | 12,578 | 14,757 |
| Total current assets | - | 49,557 | 53,759 | 56,143 | 58,047 |
| Property, plant and equipment, net | - | 10,936 | 10,796 | 11,263 | 18,709 |
| Marketable securities, non-current | - | 12,223 | 14,385 | 15,654 | 12,327 |
| Total non-current assets | - | 33,739 | 33,378 | 34,601 | 42,487 |
| Total assets | - | 83,297 | 87,138 | 90,745 | 100,534 |
| Accounts payable | - | 3,118 | - | - | - |
| Short-term debt | - | 300 | 300 | 300 | 2,521 |
| Long-term debt, current | - | 1,423 | 3,138 | 4,680 | 1,940 |
| Total current liabilities | - | 16,011 | 17,650 | 23,968 | 22,879 |
| Total non-current liabilities | - | 18,393 | 14,954 | 4,846 | 8,459 |
| Total liabilities | - | 34,404 | 32,604 | 28,815 | 31,339 |
| Retained earnings | - | 45,833 | 49,619 | 56,372 | 59,545 |
| Stockholders' equity | 44,510 | 48,892 | 54,533 | 61,930 | 69,195 |